A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
Bristol-Myers Squibb
Bristol-Myers Squibb
Brigham and Women's Hospital
Hoffmann-La Roche
Apollomics Inc.
Leiden University Medical Center
Hoffmann-La Roche
Maastricht Radiation Oncology
University of Utah
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)